DCM
SLRN

DAFNA Capital Management’s ACELYRIN SLRN Stock Holding History

DAFNA Capital Management’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-87,989
Closed -$276K – 89
2024
Q4 		$276K Sell
87,989
-514,905
-85% -$2.49M 0.07% 79
2024
Q3 		$2.97M Sell
602,894
-90,715
-13% -$468K 0.7% 35
2024
Q2 		$3.06M Buy
693,609
+491,022
+242% +$2.3M 0.73% 35
2024
Q1 		$1.37M Sell
202,587
-168,613
-45% -$1.28M 0.31% 56
2023
Q4 		$2.77M Buy
371,200
+363,900
+4,985% +$3.11M 0.66% 38
2023
Q3 		$74.2K Buy
+7,300
New +$155K 0.02% 75

Other funds holding SLRN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return